You have 7 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

GO5R2

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

ECG, Pharmacokinetics, Safety Trial in Worldwide (Gemtuzumab Ozogamicin)

Completed
Has Results
  • ECG
  • +2 more
  • Gemtuzumab Ozogamicin
  • Augusta, Georgia
  • +23 more
Feb 28, 2022

Type 2 Diabetes Trial in Worldwide (Tirzepatide, Antihyperglycemic medication)

Not yet recruiting
  • Type 2 Diabetes
  • Birmingham, Alabama
  • +96 more
Aug 8, 2022

Aging Trial in Glendale

Withdrawn
  • Aging
  • (1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol
  • Control
  • Glendale, Arizona
    Glencroft Senior Living: Retirement Community in Arizona
Jan 30, 2023

Dementia Trial in Oakville, Toronto (Immersive VR Therapy in Head-Mounted Device (HMD))

Not yet recruiting
  • Dementia
  • Immersive VR Therapy in Head-Mounted Device (HMD)
  • Oakville, Ontario, Canada
  • +3 more
May 10, 2023

LGMD2E/R4, LGMD2D/R3, and LGMD2C/R5, = 4 Years of Age, Who Are

Recruiting
  • Limb-girdle Muscular Dystrophy
    • Phoenix, Arizona
    • +14 more
    Aug 23, 2022

    Diabetes Type 2 With Proteinuria, Diabetes, Type 2, Diabetes Trial (drug, device, diagnostic test, behavioral)

    Not yet recruiting
    • Diabetes Mellitus Type 2 With Proteinuria
    • +12 more
    • Empagliflozin 10 MG
    • +6 more
    • (no location specified)
    Oct 17, 2023

    General Psychopathology, Fatigue, Depressive Disorder, Major Trial in Münsterlingen (Integrated 5-day Gratitude Exercise and

    Recruiting
    • General Psychopathology
    • +2 more
    • Integrated 5-day Gratitude Exercise and Behavioral Activation Program
    • Münsterlingen, Thurgau, Switzerland
      Psychiatric Service Thurgau
    Sep 15, 2022

    Malaria, Plasmodium Falciparum Trial (Matrix-M with RH5.2 VLP and/or R21)

    Not yet recruiting
    • Malaria, Plasmodium Falciparum
    • Matrix-M with RH5.2 VLP and/or R21
    • (no location specified)
    Oct 21, 2022

    Endometrial Tumors Trial in Worldwide (Pembrolizumab, Lenvatinib, Paclitaxel)

    Active, not recruiting
    Has Results
    • Endometrial Neoplasms
    • Phoenix, Arizona
    • +168 more
    Nov 23, 2022

    COVID-19 Trial in Canada (Artesunate, Imatinib, Infliximab)

    Recruiting
    • COVID-19
    • Calgary, Alberta, Canada
    • +56 more
    Jan 12, 2023

    COVID-19 Trial in Campos Dos Goytacazes (AZVUDINE, AZVUDINE )

    Completed
    • COVID-19
    • Campos Dos Goytacazes, RJ, Brazil
      Santa Casa de Misericordia de Campos
    Aug 10, 2022

    Bioequivalence Trial in Erfurt (Rivastigmine twice-weekly 9,5 mg/24 h, Exelon® 9.5 mg/24 h)

    Active, not recruiting
    • Bioequivalence
    • Rivastigmine twice-weekly 9,5 mg/24 h
    • Exelon® 9.5 mg/24 h
    • Erfurt, Thuringia, Germany
      SocraTec R&D GmbH, Clinical Pharmacology Unit
    May 22, 2023

    Early Breast Cancer Trial in Worldwide (drug, procedure, radiation)

    Active, not recruiting
    Has Results
    • Early Breast Cancer
    • Rockville, Maryland
    • +106 more
    Jan 19, 2023

    Gaining Insight Into the Complexity of Pain in Haemophilia

    Recruiting
    • Hemophilia A
    • Hemophilia B
    • Biopsychological pain assessment
    • Edegem, Antwerp, Belgium
    • +1 more
    Nov 3, 2022

    Gingivitis, Plaque Trial in Mississauga (Colgate (R) Cavity Protection Toothpaste, Colgate (R) Cello Toothbrush, Prototype 1

    Completed
    • Gingivitis
    • Plaque
    • Colgate (R) Cavity Protection Toothpaste
    • +6 more
    • Mississauga, Ontario, Canada, Canada
      All Sum Research Center Ltd.; 6635 Kitimat Road, Units 36 & 37
    May 16, 2022

    Hip Osteoarthritis Trial in Winnipeg, London (Pinnacle Gription Acetabular Cup, Pinnacle Dual Mobility)

    Active, not recruiting
    • Hip Osteoarthritis
    • Pinnacle Gription Acetabular Cup
    • Pinnacle Dual Mobility
    • Winnipeg, Manitoba, Canada
    • +1 more
    Jun 26, 2023

    Crohn Disease Trial in Worldwide (Etrolizumab)

    Active, not recruiting
    • Crohn Disease
    • Arcadia, California
    • +291 more
    Nov 11, 2022

    Depression, Anxiety, Quality of Life Trial in Winnipeg (Focused ACT)

    Active, not recruiting
    • Depression
    • +3 more
    • Focused ACT
    • Winnipeg, Manitoba, Canada
    • +2 more
    Nov 1, 2022

    FGFR Testing by Either ctDNA Blood Testing or Standard Tumor

    Recruiting
    • Metastatic Bladder Cancer
    • Metastatic Urothelial Carcinoma
    • FGFR Testing
    • Calgary, Alberta, Canada
    • +6 more
    Nov 8, 2023

    Pneumococcal Vaccines Trial in Canada (IVT PCV-25 Formulation A, IVT PCV-25 Formulation B, IVT PCV-25 Formulation C)

    Not yet recruiting
    • Pneumococcal Vaccines
    • IVT PCV-25 Formulation A
    • +3 more
    • Vancouver, British Columbia, Canada
    • +3 more
    Oct 10, 2023

    Prostate Cancer Metastatic Trial in Canada (Ablative Radiation Therapy, Standard of care)

    Recruiting
    • Prostate Cancer Metastatic
    • Ablative Radiation Therapy
    • Standard of care
    • Victoria, British Columbia, Canada
    • +14 more
    Nov 14, 2022

    Papulopustular Rosacea Trial in Canada (Lotilaner Gel, 2.0%, Vehicle control gel)

    Recruiting
    • Papulopustular Rosacea
    • Lotilaner Gel, 2.0%
    • Vehicle control gel
    • Oakville, Ontario, Canada
    • +4 more
    Apr 20, 2023

    Graves' Ophthalmopathy (GO) Trial in Worldwide (RVT-1401 (Administered via subcutaneous injection), Placebo (Administered via

    Terminated
    Has Results
    • Graves' Ophthalmopathy (GO)
    • RVT-1401 (Administered via subcutaneous injection)
    • Placebo (Administered via subcutaneous injection)
    • Beverly Hills, California
    • +24 more
    Aug 26, 2022

    Brodalumab in Plaque Psoriasis to Understand Impact on Quality

    Recruiting
    • Psoriasis
    • Brodalumab
    • Matched cohort
    • Calgary, Alberta, Canada
    • +33 more
    Oct 8, 2022

    Crohn's Disease Trial in Edmonton (Synbiotic, Digestible Maltodextrin)

    Recruiting
    • Crohn's Disease
    • Synbiotic
    • Digestible Maltodextrin
    • Edmonton, Alberta, Canada
    • +4 more
    Jan 10, 2023